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Abstract 
Nitric oxide (NO) production from exogenous NG-hydroxy-L-arginine (OH-L-Arg) was investigated in rat aortic smooth muscle cells in culture 
by measuring nitrite accumulation in the culture medium. As well, the interaction between OH-L-Arg and L-arginine uptake via the y+ cationic amino 
acid transporter was studied. In cells without NO-synthase activity, OH-L-Arg (l-1000 ,uM) induced a dose-dependent itrite production with a 
half-maximal effective concentration (EC,,) of 18.0 f 1.5 PM (n = 4-7). This nitrite accumulation was not inhibited by the NO-synthase inhibitor 
No-nitro+arginine methyl ester, L-NAME (300 PM). In contrast, it was abolished by miconaxole (100 pM), an inhibitor of cytochrome PJ5@ 
Incubation of vascular smooth muscle cells with LPS (10 &ml) induced an L-NAME inhibited nitrite accumulation, but did not enhance the 
OH-L-Arg induced nitrite production. OH-L-Arg and other cationic amino acids, L-lysine and L-ornithine, competitively inhibited [3H]-L-arginine 
uptake in rat aortic smooth muscle cells, with inhibition constants of 195 f 23 ,uM (a = 12), 260 & 4OpM (n = 5) and 330 f 10pM (n = 5), respectively. 
These results show that OH-L-Arg is recognized by the cationic ~-amino acid carrier present in vascular smooth muscle cells and can be oxidized 
to NO and nitrite in these cells in the absence of NO-synthase, probably by cytochrome P4M or by a reaction involving a cytochrome P4r,, by- 
product. 
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1. Introduction 
NG-hydroxy+arginine (OH-L-Arg) is a stable inter- 
mediate compound formed during the two-step enzy- 
matic reaction leading to the production of nitric oxide 
(NO) and L-citrulline from L-arginine by NO-synthases 
[1,2,3]. It has been shown that OH-L-Arg is released into 
the extracellular medium by cells which possess an NO- 
synthase [2,4,5]. This suggests that OH-L-Arg might pro- 
duce paracrine or endocrine effects, provided that it can 
enter into other cells once released in the extracellular 
fluid. The aim of the present investigation was to explore 
this possibility in vascular smooth muscle cells. It has 
been reported that OH-L-Arg is able to produce endothe- 
lium-dependent relaxation in blood vessels [6]. 
The role of NO in the regulation of vascular tone is 
well-documented (for review, see [7]). In the vessel wall, 
NO is produced by constitutive NO-synthases in endo- 
thelial cells and in some neurons, and diffuses to smooth 
muscle cells where it induces relaxation via activation of 
soluble guanylyl cyclase. Vascular smooth muscle cells 
do not contain a constitutive NO-synthase, but an induc- 
*Corresponding author. 
Abbreviations: OH-L-Arg, NG-hydroxy+arginine; L-NAME, NG- 
nitro-L-arginine methyl ester; LPS, lipopolysaccharide; HBSS, Hank’s 
balanced salt solution; NO, nitric oxide. 
ible NO-synthase can be expressed in these cells follow- 
ing exposure to bacterial ipopolysaccharide (LPS; [S]) or 
cytokines [9]. 
We report here the effects of OH-L-Arg on NO pro- 
duction in cultured rat aortic smooth muscle cells in 
control conditions and after exposure to LPS and the 
associated induction of NO-synthase. NO production 
was assessed by monitoring the accumulation of nitrite, 
the stable breakdown product of NO, in the culture me- 
dium. Since a cationic amino acid carrier transporting 
L-arginine has been recently characterized in cultured rat 
aortic smooth muscle cells [lO,l 11, the interaction of OH- 
L-Arg with this system was investigated by studying com- 
petition with [3H]L-arginine uptake. 
2. Materials and methods 
2.1. Materials 
Papain, bovine serum albumin, dithiothreitol, NG-nitro+arginine 
methyl ester (L-NAME), L-ornithine, L-arginine, and ascorbic acid were 
obtained from Sigma (St. Louis, MI, USA). Hank’s balanced salt solu- 
tion (I-IBSS), Ham’s FlO, trypsin (1.5 g/l) and Eagle’s minimum essen- 
tial medium (MEM) were purchased from Eurobio (Les Ulis, France), 
Ultroser G (a defined serum substitute) from IBF (Villeneuve la 
Garenne, France), glutamine from Merck (Darmstadt, Germany). 
[‘H]L-arginine (58.4 Wmmol) was obtained from DuPont de Nemours 
(Bad Homburg, Germany), L-lysine from Calbiochem (San Diego, CA, 
USA) and LPS (E. coli 055: B5) from Difco (Detroit, MI, USA). 
OH-L-Arg, synthesized according to a previously described method 
[12], was kindly provided by Dr. J.L. Boucher (Laboratoire de Chimie 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDZ 0014-5793(94)00198-5 
204 C.A. Schott et al. IFEBS Letters 341 (1994) 203-207 
et Biochimie Pharmacologiques et Toxicologiques, CNRS URA 400, 
Paris, France). L-NAME, L-lysine, L-omithine, L-arginine, LPS and 
OH-L-Arg solutions were freshly prepared before each experiment in 
MEM without arginine. Stock solutions of papain (1.5 mg/ml), bovine 
serum albumin (0.2%), and dithiothreitol(1 mM) were stored frozen. 
2.2. Cell cultures 
Vascular smooth muscle cells were obtained from thoracic aortae of 
male Wistar rats (9 weeks old) according to the method described by 
Clapp and Gurney [12] and used at the first passage. Briefly, aortae 
were dissected out, placed in HBSS, and connective tissue, endothelium 
and adventitia were mechanically removed. The medial layers were 
washed and incubated overnight at 4°C in HBSS containing papain 
(0.15 mg/ml) and bovine serum albumin (0.02%). After 17 h, dithiothre- 
itol (0.1 mM) was added, and the preparation was gently agitated at 
37°C for 20 min. The medial ayers were then transferred to &e culture 
medium (Ham’s FlO and MEM. 1:l v/v. sunalemented with 2% Ul- 
troser G,‘O.OS mM ascorbic acid ‘and 2 &M gutamine) and cells were 
dissociated by trituration. After preplating, used to obtain pure vascu- 
lar smooth muscle cell cultures [14], the cell suspension was transferred 
into 24-well cluster trays (Costar) and placed at 37’C in a humidified 
incubator, gassed with 95% sir/5% CO,. When confluence was reached, 
the cultures were passaged once using 1.5 g/l trypsin. The medium was 
changed every 3 days. 
2.3. Incubation of cells and nitrite determination 
Confluent vascular smooth muscle cells were incubated for 24 h in 
MEM without L-arginine, in the absence or presence of OH-L-Arg 
(l-1000 PM), with L-NAME (300 PM), miconazole (1OOpM) or LPS 
(10 mg/ml) alone or in various combinations, as indicated. Thereafter, 
nitrite concentrations were determined in the medium using Griess’ 
reagent (1% sulfanilamide, 0.1% napthylethylenediamine, 2.5% 
orthophosphoric acid). Briefly, 100 ml of Griess’ reagent was mixed 
with an equal volume of medium, and optical density was determined 
at 540 mn after IO min. 
2.4. Interaction of OH-L-arg and cationic amino acids with 
[3H]ill;-arginine uptake 
Interactions with L-a&nine transport were studied in rat aortic 
smooth muscle cells cultured as indicated above. [3H]L-Arginine uptake 
was assayed in cells cultured on 24-well cluster trays using the methods 
described by Gazzola et al. [15]. Briefly, confluent cells were washed 
and incubated in HBSS for 60 min at 37’C. The HBSS was then 
removed and the assay was initiated by the simultaneous addition to 
each well of 0.2 ml HBSS containing [‘I-I&-arginine (at the indicated 
concentrations) and various concentrations of L-arginine, OH-L-Arg, 
L-lysine or L-omithine. Experiments were performed at 37’C with an 
incubation time of 1 min. The assay was terminated by washing 3 times 
with ice-cold phosphate-buffered saline (NaCl 137 mM, KC1 2.7 mM, 
Na,HPO, 3.38 mM, KH,PQ 1.47 mM, pH 7.4). The incubation time 
was chosen in view of the results of preliminary experiments howing 
that [31-I&-arginine uptake was linear for 3 min in these conditions. 
After extraction with 10% trichloroacetic acid, 200 ~1 aliquots were 
taken for determination of rI-I&-arginine by scintillation counting. 
2.5. Statistical analysis 
Results are expressed as mean & standard error mean (S.E.M.) of n 
experiments, n representing the number of wells studied. Statistical 
comparisons were made using ANOVA and Student’s t-test as indi- 
cated. P values less than 0.05 were considered to be statistically signif- 
icant. Concentrations giving half-maximal effects (EC,) or 50% inhibi- 
tion (IC3 and slope factors were calculated by lo&-log regression. 
The x&$ne up&e inhibition constant values (@ were calculated 
from I&, values according to Cheng and Prussof [16], using a Michaelis 
constant (&) value of 105 PM for [3H]L-arginine [ll]. 
3. Results 
3.1. Effect of OH-L-Arg on nitrite production 
Incubation of aortic smooth muscle cells with OH-L- 
Arg induced a concentration dependent increase in ni- 
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Fig. 1. Nitrite production by vascular smooth muscle cells incubated 
for 24 h in the presence of OH-L-Arg. Results are presented as 
mean + S.E.M., n = 4-7. 
trite accumulation in the culture medium (Fig. 1). The 
half-maximal effect was obtained with 18.0 f 1.5 PM 
(n = 4-7) and maximal nitrite accumulation was ob- 
tained with 100pM. This effect was not due to spontane- 
ous oxidation, since in the absence of cells, no significant 
increase in nitrite was detected. Incubation of vascular 
smooth muscle cells with L-arginine (300 mM) was with- 
out effect on nitrite concentrations in the medium 
(1.83 + 0.69 PM and 1.87 + 0.1 ,uM, in the absence and 
presence of L-arginine, respectively; n = 3-5). 
As shown in Fig. 2, L-NAME (300 mM) was without 
significant effect on basal and OH-L-Arg induced nitrite 
production. For example, with 100 ,uM OH-L-Arg, ni- 
trite concentrations were respectively 17.91 + 0.41 and 
17.25 f 0.66 PM, in the absence and presence of 
L-NAME. These data are consistent with the absence of 
NO-synthase activity in rat aortic smooth muscle cells, 
under these experimental conditions. In contrast, micon- 
azole (100 PM) an inhibitor of cytochrome PdsO, reduced 
nitrite production elicited by OH-L-Arg at both concen- 
trations used to basal levels (Fig. 2). 
3.2. Effect of NO-synthase induction on OH-L-Arginine 
induced nitrite production 
As shown in Fig. 3, incubation of smooth muscle cells 
with LPS induced a significant increase in nitrite concen- 
tration. This increase could be prevented by co-incuba- 
tion with L-NAME (300 PM, data not shown), consistent 
with the induction of an inducible NO-synthase. In the 
presence of OH-L-Arg, LPS did not increase significantly 
nitrite accumulation compared to OH-L&g alone 
(Fig. 3). The results show that the effects of LPS and OH- 
L-Arg on nitrite production were not additive. 
3.3. rH]L-Arginine uptake 
The effect of OH-L-Arg on L-arginine uptake in rat 
aortic smooth muscle cells was compared with those of 
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Fig. 2. Histograms depicting the effects of OH-L-Arg (30-100 PM) 
alone (open columns), or together with L-NAME (300 ,uM, closed 
columns) or miconazole (lOOpM, hatched columns) on nitrite accumu- 
lation in rat aortic smooth muscle cell cultures. Results are presented 
as mean f S.E.M., n = Q3. Significant difference between groups: 
*P < 0.001. 
cationic amino acids which enter into cells through the 
y+ transporter. As illustrated in Fig. 4, [3H]L-arginine 
(100 PM) uptake was inhibited in a concentration- 
dependent manner by L-lysine, L-ornithine and OH-L- 
Arg. The pi values calculated from the I&, values of the 
curves illustrated in Fig. 4 were 260 + 40 PM (n = 5) for 
L-lysine, 330 + 10 mM (n = 5) for L-ornithine and 
195 f 23 mM (n = 12) for OH-L-Arg. In slightly different 
conditions (70 PM [3H]L-arginine), the Ki for L-arginine 
was 118 f 18 PM (n = 4, data not shown). Furthermore, 
the uptake could be totally abolished by these com- 
pounds. In all cases, the slope factor was not significantly 
different from unity, indicating that the interaction was 
competitive. 
4. Discussion 
The present results show that in vascular smooth mus- 
cle cells, exogenous OH-L&g is recognized by the L- 
arginine transporter and is oxidized into nitrite, inde- 
pendently of the induction of a NO-synthase. 
In the absence of LPS, only a very slight nitrite pro- 
duction was detected, which was not inhibited by L- 
NAME. Thus, consistent with a previous report [8], rat 
aortic smooth muscle cells used here exhibited no signif- 
icant NO-synthase activity. At the concentration used 
here (300 PM), L-NAME abolished LPS-induced nitrite 
formation (this study) and cyclic GMP accumulation [8] 
in rat aortic smooth muscle cells. The presently reported 
lack of effect of L-NAME on the conversion of OH-L- 
Arg into nitrite supports the view that a pathway not 
involving NO-synthase accounts for this conversion in 
smooth muscle cells. Such a pathway may also exist in 
endothelial cells, since it has been previously reported 
that L-NAME is also unable to abolish the endothelium- 
dependent relaxation induced by OH-L-Arg [17]. 
Contrary to L-NAME, miconazole, an inhibitor of cy- 
tochrome P450, abolished nitrite production elicited by 
exposure to OH-L-Arg. This finding suggests that cyto- 
chrome Pd5,, is able to catalyze the conversion of OH-L- 
Arg to NO in vascular smooth muscle cells. Such an 
oxidation of OH-L-Arg to citrulline and NO has been 
recently described in rat liver microsomes [18], in which 
a cytochrome PdsO of the 3A subfamily is mainly respon- 
sible for the oxidation. In addition, based on the hypo- 
thetical reaction scheme proposed by Klatt et al. [3] for 
NO-synthase, the sequence of electron transfers and the 
involvement of a hydroxylating ferry1 compound are in 
accord with established cytochrome PJ5,, chemistry. 
Thus, cytochrome PdsO is able to catalyze the second step 
of the conversion of L-arginine to L-citrulline and NO, 
through the intermediate formation of OH-L&g. Other 
oxidases are also able to catalyze this second step [19], 
but the inhibition by miconazole suggests that cyto- 
chrome PdsO accounts for at least a large part of the 
conversion of OH-L-Arg to NO in rat aortic smooth 
muscle cells. Alternatively, a cytochrome PdsO by-product 
such as hydrogen peroxide or superoxide might indi- 
rectly be involved in oxidation of OH-L-Arg by another 
enzyme. 
The y+ transport system for cationic amino acids has 
been characterized in many tissues [20], including rat 
aortic smooth muscle cells [lo], where it accounts for 
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Fig. 3. Histograms showing the effect of solvent (open columns) and 
LPS (10 &ml, hatched columns) on nitrite accumulation in the me- 
dium of rat aortic smooth muscle cell cultures incubated with or 
without OH-L-Arg (0,30 or 1OOpM). Results are expressed as the mean 
f S.E.M., n = 47. Sign&ant difference between groups: *P < 0.001. 
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Fig. 4. Inhibition of [‘H]L-arginine (100 PM) uptake into rat aortic 
smooth muscle cells in the presence of various concentrations of L- 
lysine (o), L-ornithine (0) or OH-L-Arg (0). Mean f S.E.M., n = 4-5. 
L-arginine uptake [ 111. Competitive inhibition of [3H]~- 
arginine uptake by L-lysine, L-ornithine and OH-L-Arg 
and the corresponding Ki values found here, are consis- 
tent with OH-L-Arg interacting with this transporter 
with an affinity comparable to those of L-lysine and L- 
ornithine. It is therefore likely that OH-L-Arg enters into 
vascular smooth muscle cells via this transporter, as does 
L-arginine. 
The Ki value of OH-L-Arg for the L-arginine trans- 
porter found here (195 ,uM) is about lo-fold higher than 
the concentration producing half-maximal nitrite pro- 
duction (18 PM). Such an apparent discrepancy between 
the K, or Ki values of L-arginine for its transporter 
(about 100 PM) and the concentration producing half- 
maximal relaxation (8 ,uM) in rat aortic rings exposed to 
LPS, has also been described previously [11,21]. K, val- 
ues of L-arginine and OH-L-Arg are respectively about 
100 and 200 PM for the transporter [l 1 and this study] 
and about 1 to 10,~M for NO-synthase [2,3]. Due to the 
low K, of the enzyme compared to the transporter, the 
intracellular substrate concentration allowing maximal 
enzyme velocity may be reached in the presence of ex- 
tracellular substrate concentrations far below those satu- 
rating the transporter, if the capacity of the transporter 
is sufficient. However, the K,,, of OH-L-Arg for cyto- 
chrome Pd5,, is still unknown. In addition, it cannot be 
ruled out that OH-L-Arg enters into rat aortic smooth 
muscle cells through another (unidentified) transporter, 
other than that for r.-arginine, thus perhaps accounting 
in part for NO production at low OH-r_-Arg concentra- 
tions. 
The lack of additive effects of LPS and OH-L-Arg on 
nitrite formation is also consistent with the view that 
C.A. Schott et al. IFEBS Letters 341 (1994) 203-207 
intracellular oxidase activity was sufficient to entirely 
convert OH-L-Arg, entering into cells into NO, even in 
the absence of NO-synthase. However, the mechanisms 
underlying the interactions of LPS and OH-L-Arg may 
be complex. For example, an inhibition of the inducible 
NO-synthase by NO produced from OH-L-Arg and cyto- 
chrome P450 might be involved. Such a regulation has 
been described for the constitutive brain NO-synthase 
[22]. In addition, OH-L-Arg may react with NO to form 
a more stable compound [17,23], thereby decreasing its 
degradation to nitrite. Thus, various mechanisms with 
opposing effects on nitrite formation may be responsible 
for the absence of additive effects of LPS and OH-L- 
Arg. 
Taken together, the present results show that OH-L- 
Arg can enter into vascular smooth muscle cells, where 
it is oxidized into NO, independently of the presence of 
NO-synthase, and further degraded into nitrite. These 
findings suggest hat OH-L-Arg released from some cells 
may exert paracrine actions on vascular smooth muscle 
cells, especially when it is formed in large quantities. This 
might be the case in endotoxemia, during which a large 
increase in NO production in blood vessels accounts for 
cyclic GMP accumulation and hyporeactivity to vaso- 
constrictor agents [8,24]. 
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